A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2
Clinical trial NCT04721535 · TERMINATED
Trial details
- NCT number
- NCT04721535
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-07
- Primary completion
- 2021-09-23
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.